Literature DB >> 26900831

In Vivo Confocal Microscopy and Biomicroscopy of Filtering Blebs After Trabeculectomy.

Cagatay Caglar1, Nafiz Karpuzoglu, Muhammed Batur, Tekin Yasar.   

Abstract

PURPOSE: The aim of this study is to analyze filtering blebs (FBs) after trabeculectomy with in vivo confocal microscopy (IVCM) and slit-lamp biomicroscopy.
MATERIALS AND METHODS: IVCM using the Heidelberg Retina Tomograph/Rostock Cornea Module and biomicroscopic examination were performed in 67 FBs in 55 patients 3 months to 30 years postoperatively (mean, 3.2 ± 2.1 y). Although the blebs were evaluated by slit-lamp biomicroscopy, standardized FB classification was used.
RESULTS: Of the patients, 9 were female (16.3%) and 46 were male (83.7%), ranging in age from 32 to 81 (51.5 ± 13.2) years. The absence of vascularization and tortuous vessels and the presence of epithelial microcysts on the bleb were significantly correlated with good bleb function (P=0.001). IVCM findings significantly correlated with good bleb function, including the number of epithelial microcysts (P=0.002), the stromal cysts without capsule (P<0.001), minimal vascularization (P=0.002), and the absence of tortuous conjunctival vessels (P=0.003) and reticular and trabecular bleb patterns (P=0.01 and <0.01, respectively). In contrast, a hyperreflective condensed bleb stroma was significantly associated with bleb failure (P<0.001).
CONCLUSIONS: IVCM supports biomicroscopic evaluation as the mainstay for FB analysis and permits diagnostic imaging of FBs to evaluate and follow-up the bleb, differentiation between good and insufficient bleb function, and a microscopic analysis at a cellular level including the structural pattern of the bleb.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26900831     DOI: 10.1097/IJG.0000000000000377

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Relationship between filtering bleb vascularization and surgical outcomes after trabeculectomy: an optical coherence tomography angiography study.

Authors:  Xue Yin; Qinhua Cai; Run Song; Xuefei He; Peirong Lu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-12       Impact factor: 3.117

2.  Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy.

Authors:  Silvio DI Staso; Luca Agnifili; Angela DI Gregorio; Hilary Climastone; Emilio Galassi; Vincenzo Fasanella; Marco Ciancaglini
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

3.  Evaluation of Successful and Failed Filtering Blebs after Trabeculectomy Using Anterior Segment Optical Coherence Tomography.

Authors:  Serek Tekin; Erbil Seven; Muhammed Batur; Muhammet Derda Özer; Tekin Yasar
Journal:  J Curr Ophthalmol       Date:  2021-03-26

4.  Optical Coherence Tomography Angiography Evaluation of Conjunctival Vessels During Filtering Surgery.

Authors:  Stéphanie Hayek; Antoine Labbé; Emmanuelle Brasnu; Pascale Hamard; Christophe Baudouin
Journal:  Transl Vis Sci Technol       Date:  2019-07-03       Impact factor: 3.283

5.  Comparison of Ex-PRESS implantation versus trabeculectomy combined with phacoemulsification in primary open-angle glaucoma: a retrospective in vivo confocal microscopy study.

Authors:  Yuqiao Zhang; Beiting He; Yulin Zhang; Jin Zeng; Yanlei Chen; Yongyi Niu; Honghua Yu; Yongjie Qin; Hongyang Zhang
Journal:  Eye Vis (Lond)       Date:  2022-02-10

6.  Effect of valproic acid on functional bleb morphology in a rabbit model of minimally invasive surgery.

Authors:  Zhu Li Yap; Li-Fong Seet; Stephanie Wl Chu; Li Zhen Toh; Farah Ilyana Ibrahim; Tina T Wong
Journal:  Br J Ophthalmol       Date:  2021-07-15       Impact factor: 5.908

7.  Characteristic Assessment of Angiographies at Different Depths with AS-OCTA: Implication for Functions of Post-Trabeculectomy Filtering Bleb.

Authors:  Man Luo; Yingting Zhu; Hui Xiao; Jingjing Huang; Jin Ling; Haishun Huang; Yiqing Li; Yehong Zhuo
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.